Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori

M. Suzuki, Hidekazu Suzuki, T. Kitahora, M. Miyazawa, S. Nagahashi, K. Suzuki, H. Ishii

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aim: To examine whether proton pump inhibitors modify the production of oxygen-derived free radicals and related cytokines in the human gastric mucosa infected with H. pylori. Methods: Thirty-four H. pylori-positive peptic ulcer patients (23 gastric ulcer, 11 duodenal ulcer) were enrolled. Biopsy tissue samples were obtained endoscopically from the antrum and corpus. Tissue content of neutrophil myeloperoxidase (myeloperoxidase) and IL-8 was measured by ELISA. Mucosal production of oxygen-derived free radical was measured using luminol-dependent chemiluminescence (ChL). A proton pump inhibitor (either lansoprazole 30 mg, omeprazole 20 mg, or rabeprazole 10 mg) was administered daily by mouth to all patients for 8 weeks. Endoscopic examination was then repeated, and biochemical analysis was performed. Results: Antral myeloperoxidase decreased significantly after proton pump inhibitor treatment (5.23 ± 7.00-2.76 ± 5.11 ng/mg, P < 0.02), but corpus myeloperoxidase was unchanged. IL-8 was also modified by proton pump inhibitors and these changes were parallel to those of myeloperoxidase. Corpus ChL was significantly increased from 88.5 ± 69.8-159 ± 172 counts/ 10 s/mg after proton pump inhibitor treatment, whereas antrum ChL was not altered. H. pylori infection rate was decreased in the antrum as well as the corpus. Conclusions: Proton pump inhibitor treatment stimulated oxygen-derived free radical production in the corpus mucosa.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalAlimentary Pharmacology and Therapeutics, Supplement
Volume16
Issue number2
Publication statusPublished - 2002 Apr

Fingerprint

Proton Pump Inhibitors
Gastric Mucosa
Helicobacter pylori
Peroxidase
Luminescence
Free Radicals
Oxygen
Interleukin-8
Rabeprazole
Lansoprazole
Luminol
Omeprazole
Helicobacter Infections
Stomach Ulcer
Duodenal Ulcer
Peptic Ulcer
Mouth
Mucous Membrane
Neutrophils
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Suzuki, M., Suzuki, H., Kitahora, T., Miyazawa, M., Nagahashi, S., Suzuki, K., & Ishii, H. (2002). Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. Alimentary Pharmacology and Therapeutics, Supplement, 16(2), 229-234.

Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. / Suzuki, M.; Suzuki, Hidekazu; Kitahora, T.; Miyazawa, M.; Nagahashi, S.; Suzuki, K.; Ishii, H.

In: Alimentary Pharmacology and Therapeutics, Supplement, Vol. 16, No. 2, 04.2002, p. 229-234.

Research output: Contribution to journalArticle

Suzuki, M, Suzuki, H, Kitahora, T, Miyazawa, M, Nagahashi, S, Suzuki, K & Ishii, H 2002, 'Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori', Alimentary Pharmacology and Therapeutics, Supplement, vol. 16, no. 2, pp. 229-234.
Suzuki, M. ; Suzuki, Hidekazu ; Kitahora, T. ; Miyazawa, M. ; Nagahashi, S. ; Suzuki, K. ; Ishii, H. / Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. In: Alimentary Pharmacology and Therapeutics, Supplement. 2002 ; Vol. 16, No. 2. pp. 229-234.
@article{859a0d48d4734ff89d2503ada8d3d99f,
title = "Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori",
abstract = "Aim: To examine whether proton pump inhibitors modify the production of oxygen-derived free radicals and related cytokines in the human gastric mucosa infected with H. pylori. Methods: Thirty-four H. pylori-positive peptic ulcer patients (23 gastric ulcer, 11 duodenal ulcer) were enrolled. Biopsy tissue samples were obtained endoscopically from the antrum and corpus. Tissue content of neutrophil myeloperoxidase (myeloperoxidase) and IL-8 was measured by ELISA. Mucosal production of oxygen-derived free radical was measured using luminol-dependent chemiluminescence (ChL). A proton pump inhibitor (either lansoprazole 30 mg, omeprazole 20 mg, or rabeprazole 10 mg) was administered daily by mouth to all patients for 8 weeks. Endoscopic examination was then repeated, and biochemical analysis was performed. Results: Antral myeloperoxidase decreased significantly after proton pump inhibitor treatment (5.23 ± 7.00-2.76 ± 5.11 ng/mg, P < 0.02), but corpus myeloperoxidase was unchanged. IL-8 was also modified by proton pump inhibitors and these changes were parallel to those of myeloperoxidase. Corpus ChL was significantly increased from 88.5 ± 69.8-159 ± 172 counts/ 10 s/mg after proton pump inhibitor treatment, whereas antrum ChL was not altered. H. pylori infection rate was decreased in the antrum as well as the corpus. Conclusions: Proton pump inhibitor treatment stimulated oxygen-derived free radical production in the corpus mucosa.",
author = "M. Suzuki and Hidekazu Suzuki and T. Kitahora and M. Miyazawa and S. Nagahashi and K. Suzuki and H. Ishii",
year = "2002",
month = "4",
language = "English",
volume = "16",
pages = "229--234",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori

AU - Suzuki, M.

AU - Suzuki, Hidekazu

AU - Kitahora, T.

AU - Miyazawa, M.

AU - Nagahashi, S.

AU - Suzuki, K.

AU - Ishii, H.

PY - 2002/4

Y1 - 2002/4

N2 - Aim: To examine whether proton pump inhibitors modify the production of oxygen-derived free radicals and related cytokines in the human gastric mucosa infected with H. pylori. Methods: Thirty-four H. pylori-positive peptic ulcer patients (23 gastric ulcer, 11 duodenal ulcer) were enrolled. Biopsy tissue samples were obtained endoscopically from the antrum and corpus. Tissue content of neutrophil myeloperoxidase (myeloperoxidase) and IL-8 was measured by ELISA. Mucosal production of oxygen-derived free radical was measured using luminol-dependent chemiluminescence (ChL). A proton pump inhibitor (either lansoprazole 30 mg, omeprazole 20 mg, or rabeprazole 10 mg) was administered daily by mouth to all patients for 8 weeks. Endoscopic examination was then repeated, and biochemical analysis was performed. Results: Antral myeloperoxidase decreased significantly after proton pump inhibitor treatment (5.23 ± 7.00-2.76 ± 5.11 ng/mg, P < 0.02), but corpus myeloperoxidase was unchanged. IL-8 was also modified by proton pump inhibitors and these changes were parallel to those of myeloperoxidase. Corpus ChL was significantly increased from 88.5 ± 69.8-159 ± 172 counts/ 10 s/mg after proton pump inhibitor treatment, whereas antrum ChL was not altered. H. pylori infection rate was decreased in the antrum as well as the corpus. Conclusions: Proton pump inhibitor treatment stimulated oxygen-derived free radical production in the corpus mucosa.

AB - Aim: To examine whether proton pump inhibitors modify the production of oxygen-derived free radicals and related cytokines in the human gastric mucosa infected with H. pylori. Methods: Thirty-four H. pylori-positive peptic ulcer patients (23 gastric ulcer, 11 duodenal ulcer) were enrolled. Biopsy tissue samples were obtained endoscopically from the antrum and corpus. Tissue content of neutrophil myeloperoxidase (myeloperoxidase) and IL-8 was measured by ELISA. Mucosal production of oxygen-derived free radical was measured using luminol-dependent chemiluminescence (ChL). A proton pump inhibitor (either lansoprazole 30 mg, omeprazole 20 mg, or rabeprazole 10 mg) was administered daily by mouth to all patients for 8 weeks. Endoscopic examination was then repeated, and biochemical analysis was performed. Results: Antral myeloperoxidase decreased significantly after proton pump inhibitor treatment (5.23 ± 7.00-2.76 ± 5.11 ng/mg, P < 0.02), but corpus myeloperoxidase was unchanged. IL-8 was also modified by proton pump inhibitors and these changes were parallel to those of myeloperoxidase. Corpus ChL was significantly increased from 88.5 ± 69.8-159 ± 172 counts/ 10 s/mg after proton pump inhibitor treatment, whereas antrum ChL was not altered. H. pylori infection rate was decreased in the antrum as well as the corpus. Conclusions: Proton pump inhibitor treatment stimulated oxygen-derived free radical production in the corpus mucosa.

UR - http://www.scopus.com/inward/record.url?scp=0036548124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036548124&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 229

EP - 234

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 2

ER -